S. Dominici et al. novel nuclear protein. J Biol Chem 1999;274:30008-18. Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 2006;86:967-1008. Capanni C, Mattioli E, Columbaro M, Lucarelli E, Parnaik VK, Novelli G, et al. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum Mol Genet 2005;14:1489-502. Caron M, Auclair M, Donadille B, Bereziat V, Guerci B, Laville M, et al. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ 2007;14:1759-67. Caron M, Auclair M, Sterlingot H, Kornprobst M, Capeau J. Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. Aids 2003;17:2437-44. Coffinier C, Hudon SE, Farber EA, Chang SY, Hrycyna CA, Young SG, et al. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc Natl Acad Sci USA. 2007;104:13432-7. Coffinier C, Hudon SE, Lee R, Farber EA, Nobumori C, Miner JH, et al. A potent HIV protease inhibitor, darunavir, does not inhibit ZMP- STE24 or lead to an accumulation of farnesyl-prelamin A in cells. J Biol Chem 2008. Columbaro M, Capanni C, Mattioli E, Novelli G, Parnaik VK, Squarzoni S, et al. Rescue of heterochromatin organization in Hutchinson- Gilford progeria by drug treatment. Cell Mol Life Sci 2005;62:2669-78. Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, Michaelis S, et al. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 2005;387:129-38. Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, Burke B, et al. Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol 2006;172:41-53. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin a truncation in Hutchinson-Gilford proge- ria. Science 2003;300:2055. Dechat T, Shimi T, Adam SA, Rusinol AE, Andres DA, Spielmann HP, Sinensky MS, Goldman RD. 2007. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci U S A 104:4955-4960. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, et al. Recurrent de novo point mutations in lamin A cause Hutchinson- Gilford progeria syndrome. Nature 2003;423:293-8. Filesi I, Gullotta F, Lattanzi G, D'Apice MR, Capanni C, Nardone AM, et al. Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol Genomics 2005;23:150-8. Glynn MW, Glover TW. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 2005;14:2959-69. Gruber J, Lampe T, Osborn M, Weber K. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: impli- cations for Hutchinson-Gilford progeria syndrome. J Cell Sci 52 2005;118:689-696. Hennekes H, Nigg EA. The role of isoprenylation in membrane attach- ment of nuclear lamins. A single point mutation prevents proteolyt- ic cleavage of the lamin A precursor and confers membrane binding properties. J Cell Sci 1994;107:1019-29. Kilic F, Dalton MB, Burrell SK, Mayer JP, Patterson SD, Sinensky M. In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease. J Biol Chem 1997;272:5298-304. Lattanzi G, Columbaro M, Mattioli E, Cenni V, Camozzi D, Wehnert M, Santi S, Riccio M, Del Coco R, Maraldi NM, Squarzoni S, Foisner R, Capanni C. 2007a. Pre-Lamin A processing is linked to hete- rochromatin organization. J Cell Biochem 102:1149-59. Maraldi NM, Lattanzi G. 2007. Involvement of prelamin A in laminopathies. Crit Rev Eukaryot Gene Expr 17:317-34. Maraldi NM, Lattanzi G, Capanni C, Columbaro M, Merlini L, Mattioli E, et al. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies. Eur J Histochem 2006; 50:1-8. Maraldi NM, Mazzotti G, Rana R, Antonucci A, Di Primio R, Guidotti L. The nuclear envelope, human genetic diseases and ageing. Eur J Histochem 2007;51:117-24 Mattioli E, Columbaro M, Capanni C, Santi S, Maraldi NM, D'Apice MR, et al. Drugs affecting prelamin A processing: effects on hete- rochromatin organization. Exp Cell Res 2008;314:453-62. Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, Genevieve D, et al. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 2004;13:2493-503. Ramirez CL, Cadinanos J, Varela I, Freije JM, Lopez-Otin C. Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci 2007;64:155-70. Rusinol AE, Sinensky MS. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J Cell Sci 2006;119:3265-72. Taylor MR, Slavov D, Gajewski A, Vlcek S, Ku L, Fain PR,et al. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat 2005;26:566- 74. Verstraeten VL, Broers JL, van Steensel MA, Zinn-Justin S, Ramaekers FC, Steijlen PM, et al. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Hum Mol Genet 2006;15:2509-22. Vlcek S, Foisner R. Lamins and lamin-associated proteins in aging and disease. Curr Opin Cell Biol 2007;19:298-304. Yang SH, Bergo MO,Toth JI, Qiao X, Hu Y, Sandoval S, et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci USA 2005;102:10291-6. Yang SH, Qiao X, Farber E, Chang SY, Fong LG, Young SG. Eliminating the synthesis of mature lamin a reduces disease pheno- types in mice carrying a hutchinson-gilford progeria syndrome allele. J Biol Chem 2008;283:7094-9. Young J, Morbois-Trabut L, Couzinet B, Lascols O, Dion E, Béréziat V et al. Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes 2005;54:1873-8.